LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,013,347 | -25.6% | 1,101,881 | -23.5% | 0.03% | -24.4% |
| Q2 2023 | $99,464,775 | +30.7% | 1,440,892 | -8.7% | 0.04% | +24.2% |
| Q1 2023 | $76,088,604 | +18.0% | 1,577,947 | +22.2% | 0.03% | +13.8% |
| Q4 2022 | $64,481,564 | +2.9% | 1,291,698 | -15.9% | 0.03% | -3.3% |
| Q3 2022 | $62,680,000 | -22.2% | 1,536,271 | +4.8% | 0.03% | -18.9% |
| Q2 2022 | $80,609,000 | +6.7% | 1,465,620 | -29.5% | 0.04% | +27.6% |
| Q1 2022 | $75,543,000 | -20.1% | 2,078,775 | +2.5% | 0.03% | -12.1% |
| Q4 2021 | $94,506,000 | -6.5% | 2,027,599 | +1.5% | 0.03% | -17.5% |
| Q3 2021 | $101,026,000 | +29.7% | 1,998,150 | +5.3% | 0.04% | +29.0% |
| Q2 2021 | $77,871,000 | +26.6% | 1,896,983 | -10.5% | 0.03% | +14.8% |
| Q1 2021 | $61,531,000 | +77.7% | 2,120,291 | +72.5% | 0.03% | +68.8% |
| Q4 2020 | $34,622,000 | -18.9% | 1,229,459 | -11.1% | 0.02% | -30.4% |
| Q3 2020 | $42,707,000 | -6.4% | 1,383,439 | +29.0% | 0.02% | -14.8% |
| Q2 2020 | $45,641,000 | – | 1,072,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |